According to Gartner, 58% of finance functions employed AI in 2024—a 21-percentage-point jump from the prior year. PwC ...

It was the summer of 2020. Pandemic aside, things were going well for Tuyen Ong, M.D. The physician and biotech entrepreneur was heading up the opthamology franchise unit of Biogen following its ...

Koroshetz’s exit—expected Jan. 24—means that 14 of the NIH’s 27 units will be helmed by interim leaders. NINDS acting deputy ...

A group of biotechnology research companies based in Birmingham will receive $44 million in federal funding to research AI technology, federal officials announced this morning. The Birmingham ...

Researchers at Humacyte have been working for decades to bring their product to the market Humacyte makes "spare parts for people" and will hear from the Food and Drug Administration this week about ...

SHERIDAN, WY / ACCESS Newswire / December 12, 2025 / From 2024 to 2027, biotech R&D growth is increasingly shaped by a quiet enabler: high-purity research peptides. As labs pursue complex work in ...

ATLANTA, March 25, 2025 /PRNewswire/ -- Truist Securities announced today that Danielle Brill has joined the firm as managing director, strengthening its equity research coverage in the biotechnology ...

A life-sciences job in Boston used to be a sure path to a high-paying career, but empty labs and unemployed grads now herald ...

SPARTANBURG COUNTY, S.C. (WSPA) – A biotech research and development center announced that they have plans to set up operations in Spartanburg County. Related video: $19M childcare campus coming to ...

The biotechnology sector’s foundations rest on basic scientific research. Early experiments done in academic laboratories often yield the discoveries that venture investors later form drug startups ...

The recent National Institutes of Health funding cuts and proposed caps on indirect costs are raising concerns not only about the future of scientific innovation but also about potential economic ...

Biotech stocks are emerging from a four-year slump. The SPDR S&P Biotech exchange-traded fund XBI, a proxy for the sector, is up 25% so far this year through Oct. 31, beating the S&P 500 SPX by 9 ...